Literature DB >> 26490509

Handling of Drugs, Metabolites, and Uremic Toxins by Kidney Proximal Tubule Drug Transporters.

Sanjay K Nigam1, Wei Wu2, Kevin T Bush3, Melanie P Hoenig4, Roland C Blantz5, Vibha Bhatnagar6.   

Abstract

The proximal tubule of the kidney plays a crucial role in the renal handling of drugs (e.g., diuretics), uremic toxins (e.g., indoxyl sulfate), environmental toxins (e.g., mercury, aristolochic acid), metabolites (e.g., uric acid), dietary compounds, and signaling molecules. This process is dependent on many multispecific transporters of the solute carrier (SLC) superfamily, including organic anion transporter (OAT) and organic cation transporter (OCT) subfamilies, and the ATP-binding cassette (ABC) superfamily. We review the basic physiology of these SLC and ABC transporters, many of which are often called drug transporters. With an emphasis on OAT1 (SLC22A6), the closely related OAT3 (SLC22A8), and OCT2 (SLC22A2), we explore the implications of recent in vitro, in vivo, and clinical data pertinent to the kidney. The analysis of murine knockouts has revealed a key role for these transporters in the renal handling not only of drugs and toxins but also of gut microbiome products, as well as liver-derived phase 1 and phase 2 metabolites, including putative uremic toxins (among other molecules of metabolic and clinical importance). Functional activity of these transporters (and polymorphisms affecting it) plays a key role in drug handling and nephrotoxicity. These transporters may also play a role in remote sensing and signaling, as part of a versatile small molecule communication network operative throughout the body in normal and diseased states, such as AKI and CKD.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  ATP-Binding Cassette Transporters; Acute Kidney Injury; Anti-Bacterial Agents; Cations; Chronic; Diuretics; Organic Anion Transporters; Renal Insufficiency; drug transporter; nephrotoxicity; renal physiology

Mesh:

Substances:

Year:  2015        PMID: 26490509      PMCID: PMC4633783          DOI: 10.2215/CJN.02440314

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  108 in total

Review 1.  Membrane transporters in drug development.

Authors:  Kathleen M Giacomini; Shiew-Mei Huang; Donald J Tweedie; Leslie Z Benet; Kim L R Brouwer; Xiaoyan Chu; Amber Dahlin; Raymond Evers; Volker Fischer; Kathleen M Hillgren; Keith A Hoffmaster; Toshihisa Ishikawa; Dietrich Keppler; Richard B Kim; Caroline A Lee; Mikko Niemi; Joseph W Polli; Yuichi Sugiyama; Peter W Swaan; Joseph A Ware; Stephen H Wright; Sook Wah Yee; Maciej J Zamek-Gliszczynski; Lei Zhang
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

2.  Treatment of gonorrhoea with procaine penicillin plus probenecid.

Authors:  J Lesiński; D Dzierzanowska; M Szymczak; H Linda; C Wiśniewska; A Nawara; A Winogrodzka
Journal:  Br J Vener Dis       Date:  1973-08

3.  Disposition of bumetanide in the isolated perfused rat kidney: effects of probenecid and dose response.

Authors:  I Bekersky; A C Popick
Journal:  Am J Cardiol       Date:  1986-01-24       Impact factor: 2.778

4.  Development of mechanisms for drug excretion.

Authors:  J B Hook; W R Hewitt
Journal:  Am J Med       Date:  1977-04       Impact factor: 4.965

5.  A novel putative transporter maps to the osteosclerosis (oc) mutation and is not expressed in the oc mutant mouse.

Authors:  K P Brady; H Dushkin; D Förnzler; T Koike; F Magner; H Her; S Gullans; G V Segre; R M Green; D R Beier
Journal:  Genomics       Date:  1999-03-15       Impact factor: 5.736

6.  Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney.

Authors:  Tsuneo Deguchi; Sumio Ohtsuki; Masaki Otagiri; Hitomi Takanaga; Hiroshi Asaba; Shinobu Mori; Tetsuya Terasaki
Journal:  Kidney Int       Date:  2002-05       Impact factor: 10.612

7.  Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1).

Authors:  William R Wikoff; Megha A Nagle; Valentina L Kouznetsova; Igor F Tsigelny; Sanjay K Nigam
Journal:  J Proteome Res       Date:  2011-04-22       Impact factor: 4.466

8.  Evaluation of the interaction between nonsteroidal anti-inflammatory drugs and methotrexate using human organic anion transporter 3-transfected cells.

Authors:  Akimitsu Maeda; Shuichi Tsuruoka; Yoshikatsu Kanai; Hitoshi Endou; Kazuyuki Saito; Etsuko Miyamoto; Akio Fujimura
Journal:  Eur J Pharmacol       Date:  2008-08-30       Impact factor: 4.432

9.  Roles of organic anion transporters in the renal excretion of perfluorooctanoic acid.

Authors:  Hatsuki Nakagawa; Taku Hirata; Tomohiro Terada; Promsuk Jutabha; Daisaku Miura; Kouji H Harada; Kayoko Inoue; Naohiko Anzai; Hitoshi Endou; Ken-Ichi Inui; Yoshikatsu Kanai; Akio Koizumi
Journal:  Basic Clin Pharmacol Toxicol       Date:  2008-07-01       Impact factor: 4.080

10.  Hepatocyte nuclear factors 4α and 1α regulate kidney developmental expression of drug-metabolizing enzymes and drug transporters.

Authors:  Gleb Martovetsky; James B Tee; Sanjay K Nigam
Journal:  Mol Pharmacol       Date:  2013-09-13       Impact factor: 4.436

View more
  81 in total

1.  Indoxyl sulfate associates with cardiovascular phenotype in children with chronic kidney disease.

Authors:  Johannes Holle; Uwe Querfeld; Marietta Kirchner; Alexandros Anninos; Jürgen Okun; Daniela Thurn-Valsassina; Aysun Bayazit; Ana Niemirska; Nur Canpolat; Ipek Kaplan Bulut; Ali Duzova; Ali Anarat; Rukshana Shroff; Yelda Bilginer; Salim Caliskan; Cengiz Candan; Jerome Harambat; Zeynep Birsin Özcakar; Oguz Soylemezoglu; Sibylle Tschumi; Sandra Habbig; Ebru Yilmaz; Ayse Balat; Aleksandra Zurowska; Nilgun Cakar; Birgitta Kranz; Pelin Ertan; Anette Melk; Karolis Azukaitis; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2019-08-19       Impact factor: 3.714

Review 2.  The SLC22 Transporter Family: A Paradigm for the Impact of Drug Transporters on Metabolic Pathways, Signaling, and Disease.

Authors:  Sanjay K Nigam
Journal:  Annu Rev Pharmacol Toxicol       Date:  2018-01-06       Impact factor: 13.820

Review 3.  The renal molecular clock: broken by aging and restored by exercise.

Authors:  Emily E Schmitt; Evan C Johnson; Musharraf Yusifova; Danielle R Bruns
Journal:  Am J Physiol Renal Physiol       Date:  2019-08-28

4.  Clinical Pharmacology in Diuretic Use.

Authors:  David H Ellison
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-01       Impact factor: 8.237

Review 5.  Kidney Organoids: A Translational Journey.

Authors:  Ryuji Morizane; Joseph V Bonventre
Journal:  Trends Mol Med       Date:  2017-02-07       Impact factor: 11.951

Review 6.  The systems biology of uric acid transporters: the role of remote sensing and signaling.

Authors:  Sanjay K Nigam; Vibha Bhatnagar
Journal:  Curr Opin Nephrol Hypertens       Date:  2018-07       Impact factor: 2.894

7.  Dynamics of Organic Anion Transporter-Mediated Tubular Secretion during Postnatal Human Kidney Development and Maturation.

Authors:  Jeremiah D Momper; Jin Yang; Mary Gockenbach; Florin Vaida; Sanjay K Nigam
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-18       Impact factor: 8.237

8.  Residual Function Effectively Controls Plasma Concentrations of Secreted Solutes in Patients on Twice Weekly Hemodialysis.

Authors:  Sheldon C Leong; Justin N Sao; Abigail Taussig; Natalie S Plummer; Timothy W Meyer; Tammy L Sirich
Journal:  J Am Soc Nephrol       Date:  2018-05-04       Impact factor: 10.121

9.  Albumin-Based Transport of Nonsteroidal Anti-Inflammatory Drugs in Mammalian Blood Plasma.

Authors:  Mateusz P Czub; Katarzyna B Handing; Barat S Venkataramany; David R Cooper; Ivan G Shabalin; Wladek Minor
Journal:  J Med Chem       Date:  2020-06-17       Impact factor: 7.446

Review 10.  Emerging Kidney Models to Investigate Metabolism, Transport, and Toxicity of Drugs and Xenobiotics.

Authors:  Piyush Bajaj; Swapan K Chowdhury; Robert Yucha; Edward J Kelly; Guangqing Xiao
Journal:  Drug Metab Dispos       Date:  2018-08-03       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.